| Name | VACCINEX, INC. |
|---|---|
| CIK | 0001205922 |
| Tickers | VCNX |
| Exchanges | OTC |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 161603202 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 585-271-2700 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 1 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
No Financialist filing articles yet for this CIK.
475 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-15 | 10-K | 10-K | 0000950170-25-054318 | 001-38624 | 25840492 | 34 | 26812590 | 1 | 1 | |
| 2025-04-01 | NT 10-K | NT 10-K | 0001193125-25-069655 | 001-38624 | 25796539 | 34 | 23304 | |||
| 2025-03-27 | 15-12G | 15-12G | 0001193125-25-064732 | 001-38624 | 25775443 | 34 | 11260 | |||
| 2025-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000768 | 333-282679 | 25769907 | 33 | 1793 | ||
| 2025-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000765 | 333-280535 | 25769904 | 33 | 1793 | ||
| 2025-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000763 | 333-278968 | 25769902 | 33 | 1793 | ||
| 2025-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000762 | 333-278467 | 25769901 | 33 | 1793 | ||
| 2025-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000761 | 333-276465 | 25769900 | 33 | 1793 | ||
| 2025-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000758 | 333-274756 | 25769896 | 33 | 1793 | ||
| 2025-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000757 | 333-274520 | 25769894 | 33 | 1793 | ||
| 2025-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000756 | 333-272649 | 25769892 | 33 | 1793 | ||
| 2025-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000755 | 333-271074 | 25769890 | 33 | 1793 | ||
| 2025-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000754 | 333-269385 | 25769888 | 33 | 1793 | ||
| 2025-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000752 | 333-264236 | 25769883 | 33 | 1793 | ||
| 2025-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000750 | 333-246326 | 25769879 | 33 | 1793 | ||
| 2025-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000749 | 333-246322 | 25769877 | 33 | 1793 | ||
| 2025-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000747 | 333-236417 | 25769873 | 33 | 1793 | ||
| 2025-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000746 | 333-233607 | 25769870 | 33 | 1793 | ||
| 2025-03-25 | POS AM | POS AM | 0001193125-25-062021 | 333-274756 | 25766027 | 33 | 37989 | |||
| 2025-03-25 | POS AM | POS AM | 0001193125-25-062019 | 333-274520 | 25766021 | 33 | 37989 | |||
| 2025-03-25 | POS AM | POS AM | 0001193125-25-062017 | 333-282679 | 25766014 | 33 | 37989 | |||
| 2025-03-25 | POS AM | POS AM | 0001193125-25-062014 | 333-280535 | 25766013 | 33 | 37989 | |||
| 2025-03-25 | POS AM | POS AM | 0001193125-25-062009 | 333-278968 | 25766009 | 33 | 37989 | |||
| 2025-03-25 | POS AM | POS AM | 0001193125-25-062006 | 333-278467 | 25766006 | 33 | 37989 | |||
| 2025-03-25 | POS AM | POS AM | 0001193125-25-062003 | 333-276465 | 25766005 | 33 | 37989 | |||
| 2025-03-25 | POS AM | POS AM | 0001193125-25-062001 | 333-272649 | 25766001 | 33 | 37989 | |||
| 2025-03-25 | POS AM | POS AM | 0001193125-25-061999 | 333-271074 | 25765999 | 33 | 37989 | |||
| 2025-03-25 | POS AM | POS AM | 0001193125-25-061994 | 333-269385 | 25765991 | 33 | 37989 | |||
| 2025-03-25 | POS AM | POS AM | 0001193125-25-061993 | 333-264236 | 25765988 | 33 | 37989 | |||
| 2025-03-25 | POS AM | POS AM | 0001193125-25-061992 | 333-246326 | 25765986 | 33 | 37989 | |||
| 2025-03-25 | POS AM | POS AM | 0001193125-25-061991 | 333-246322 | 25765982 | 33 | 37989 | |||
| 2025-03-25 | POS AM | POS AM | 0001193125-25-061990 | 333-236417 | 25765979 | 33 | 37989 | |||
| 2025-03-25 | POS AM | POS AM | 0001193125-25-061989 | 333-233607 | 25765973 | 33 | 37989 | |||
| 2025-03-25 | S-8 POS | S-8 POS | 0001193125-25-061988 | 333-279307 | 25765971 | 33 | 19779 | |||
| 2025-03-25 | S-8 POS | S-8 POS | 0001193125-25-061986 | 333-226964 | 25765970 | 33 | 19779 | |||
| 2025-03-19 | 8-K | 8-K | 5.02 | 0001193125-25-057850 | 001-38624 | 25752935 | 34 | 140241 | 1 | 1 |
| 2025-03-17 | 25 | 25 | 0001193125-25-055645 | 001-38624 | 25745012 | 34 | 11890 | |||
| 2025-03-07 | 8-K | 8-K | 3.01,7.01,9.01 | 0001193125-25-049988 | 001-38624 | 25721287 | 34 | 159960 | 1 | 1 |
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-001211 | 005-90610 | 25630126 | 34 | 10597 | |||
| 2024-12-17 | 8-K | 8-K | 3.01,8.01,9.01 | 0001193125-24-280155 | 001-38624 | 241553839 | 34 | 161559 | 1 | 1 |
| 2024-11-18 | SC 13D/A | SC 13D/A | 0001193125-24-260927 | 005-90610 | 241471689 | 34 | 62432 | |||
| 2024-11-18 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-019266 | 15491 | ||||||
| 2024-11-18 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-019265 | 18281 | ||||||
| 2024-11-14 | 8-K | 8-K | 1.01,3.02,9.01 | 0001193125-24-258757 | 001-38624 | 241463986 | 34 | 536138 | 1 | 1 |
| 2024-11-14 | 10-Q | 10-Q | 0000950170-24-127139 | 001-38624 | 241463644 | 34 | 8561233 | 1 | 1 | |
| 2024-11-14 | SC 13G | armistice-vcnx093024.htm | 0001172661-24-005111 | 005-90610 | 241461135 | 34 | 90554 | |||
| 2024-10-25 | 424B3 | 424B3 | 0001193125-24-244137 | 333-282679 | 241397186 | 33 | 167116 | |||
| 2024-10-24 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-10-24 16:30:00 | 9999999995-24-003276 | 333-282679 | 241393942 | 33 | 1788 | ||
| 2024-10-22 | CORRESP | filename1.htm | 0001193125-24-241060 | 6055 | ||||||
| 2024-10-21 | UPLOAD | filename1.pdf | 0000000000-24-011780 | 333-282679 | 40077 | |||||
| 2024-10-16 | S-3 | S-3 | 0001193125-24-238151 | 333-282679 | 241375096 | 33 | 267597 | |||
| 2024-10-09 | 8-K | 8-K | 3.01 | 0001193125-24-235251 | 001-38624 | 241363132 | 34 | 141967 | 1 | 1 |
| 2024-09-27 | D | xslFormDX01/primary_doc.xml | 06b | 0001123292-24-000293 | 021-525279 | 241334978 | 33 | 12644 | ||
| 2024-09-20 | SC 13D/A | SC 13D/A | 0001193125-24-222994 | 005-90610 | 241314132 | 34 | 141067 | |||
| 2024-09-20 | SC 13D/A | SC 13D/A | 0001193125-24-222970 | 005-90610 | 241313986 | 34 | 69760 | |||
| 2024-09-20 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-016842 | 36003 | ||||||
| 2024-09-20 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-016838 | 19757 | ||||||
| 2024-09-19 | 8-K | 8-K | 1.01,3.02,9.01 | 0001193125-24-221790 | 001-38624 | 241309163 | 34 | 343196 | 1 | 1 |
| 2024-09-13 | 8-K | 8-K | 5.02 | 0001193125-24-218870 | 001-38624 | 241297950 | 34 | 139948 | 1 | 1 |
| 2024-08-20 | 8-K | 8-K | 8.01 | 0001193125-24-203149 | 001-38624 | 241222531 | 34 | 141211 | 1 | 1 |
| 2024-08-14 | 10-Q | 10-Q | 0000950170-24-097217 | 001-38624 | 241209572 | 34 | 7805843 | 1 | 1 | |
| 2024-08-14 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-200272 | 001-38624 | 241204374 | 34 | 236043 | 1 | 1 |
| 2024-08-13 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-014976 | 13043 | ||||||
| 2024-08-07 | SC 13D/A | SC 13D/A | 0001193125-24-195887 | 005-90610 | 241183845 | 34 | 112071 | |||
| 2024-08-07 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-014577 | 14575 | ||||||
| 2024-08-02 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-014364 | 13045 | ||||||
| 2024-08-01 | SC 13D/A | SC 13D/A | 0001193125-24-191522 | 005-90610 | 241166832 | 34 | 115950 | |||
| 2024-08-01 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-014289 | 20967 | ||||||
| 2024-07-31 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-189569 | 001-38624 | 241160042 | 34 | 173575 | 1 | 1 |
| 2024-07-08 | 424B3 | 424B3 | 0001193125-24-176303 | 333-280535 | 241104911 | 33 | 152747 | |||
| 2024-07-05 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-07-05 16:30:00 | 9999999995-24-002085 | 333-280535 | 241103265 | 33 | 1788 | ||
| 2024-07-02 | CORRESP | filename1.htm | 0001193125-24-174355 | 6971 | ||||||
| 2024-07-01 | UPLOAD | filename1.pdf | 0000000000-24-007473 | 333-280535 | 40054 | |||||
| 2024-06-27 | S-3 | S-3 | 0001193125-24-170651 | 333-280535 | 241079841 | 33 | 254115 | |||
| 2024-06-06 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-155612 | 001-38624 | 241023913 | 34 | 176379 | 1 | 1 |
| 2024-05-31 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-011556 | 18186 | ||||||
| 2024-05-15 | 10-Q | 10-Q | 0000950170-24-060603 | 001-38624 | 24952687 | 34 | 9041545 | 1 | 1 | |
| 2024-05-14 | 4/A | AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-010189 | 5920 | ||||||
| 2024-05-14 | 4/A | AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-010187 | 5935 | ||||||
| 2024-05-14 | 4/A | AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-010186 | 5961 | ||||||
| 2024-05-14 | 4/A | AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-010185 | 6123 | ||||||
| 2024-05-14 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-010184 | 13676 | ||||||
| 2024-05-14 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-010183 | 20214 | ||||||
| 2024-05-14 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-010182 | 14819 | ||||||
| 2024-05-14 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-010181 | 11013 | ||||||
| 2024-05-14 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-010179 | 40452 | ||||||
| 2024-05-10 | S-8 | S-8 | 0001193125-24-135964 | 333-279307 | 24933788 | 33 | 80394 | |||
| 2024-05-09 | 424B3 | 424B3 | 0001193125-24-135374 | 333-278968 | 24931806 | 33 | 171544 | |||
| 2024-05-09 | 8-K | 8-K | 5.07 | 0001193125-24-135285 | 001-38624 | 24930900 | 34 | 155565 | 1 | 1 |
| 2024-05-08 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-05-08 16:05:00 | 9999999995-24-001488 | 333-278968 | 24936705 | 33 | 1787 | ||
| 2024-05-08 | S-3/A | S-3/A | 0001193125-24-133969 | 333-278968 | 24925008 | 33 | 230333 | |||
| 2024-05-02 | CORRESP | filename1.htm | 0001193125-24-129388 | 7063 | ||||||
| 2024-05-02 | UPLOAD | filename1.pdf | 0000000000-24-004979 | 333-278968 | 40318 | |||||
| 2024-04-26 | S-3 | S-3 | 0001193125-24-118410 | 333-278968 | 24885292 | 33 | 274183 | |||
| 2024-04-25 | 10-K/A | 10-K/A | 0000950170-24-048163 | 001-38624 | 24875524 | 34 | 7450488 | 1 | 1 | |
| 2024-04-22 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-008643 | 13042 | ||||||
| 2024-04-16 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-04-16 16:30:00 | 9999999995-24-000987 | 333-278467 | 24849284 | 33 | 1787 | ||
| 2024-04-16 | 424B3 | 424B3 | 0001193125-24-097887 | 333-278467 | 24848504 | 33 | 159061 | |||
| 2024-04-12 | CORRESP | filename1.htm | 0001193125-24-094751 | 5977 | ||||||
| 2024-04-12 | D | xslFormDX01/primary_doc.xml | 06b | 0001123292-24-000109 | 021-510534 | 24841815 | 33 | 12398 | ||
| 2024-04-12 | D | xslFormDX01/primary_doc.xml | 06b | 0001123292-24-000107 | 021-510533 | 24841730 | 33 | 12398 | ||
| 2024-04-12 | 8-K | 8-K | 3.01 | 0001193125-24-094701 | 001-38624 | 24841705 | 34 | 141440 | 1 | 1 |
| 2024-04-12 | D | xslFormDX01/primary_doc.xml | 06b | 0001123292-24-000105 | 021-510530 | 24841633 | 33 | 13711 | ||
| 2024-04-03 | UPLOAD | filename1.pdf | 0000000000-24-003597 | 333-278467 | 40301 | |||||
| 2024-04-02 | ARS | ARS | 0001193125-24-084791 | 001-38624 | 24814719 | 34 | 3544720 | |||
| 2024-04-02 | DEF 14A | DEF 14A | 0001193125-24-084768 | 001-38624 | 24814594 | 34 | 1025837 | |||
| 2024-04-02 | S-3 | S-3 | 0001193125-24-084759 | 333-278467 | 24814315 | 33 | 267238 | |||
| 2024-04-02 | 10-K | 10-K | 0000950170-24-039700 | 001-38624 | 24811897 | 34 | 21635296 | 1 | 1 | |
| 2024-04-02 | NT 10-K | NT 10-K | 0001193125-24-083757 | 001-38624 | 24811862 | 34 | 21897 | |||
| 2024-04-01 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-007661 | 25572 | ||||||
| 2024-04-01 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-007660 | 14125 | ||||||
| 2024-04-01 | 8-K | 8-K | 1.01,3.02,5.03,9.01 | 0001193125-24-083568 | 001-38624 | 24810694 | 34 | 1384509 | 1 | 1 |
| 2024-03-28 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-080804 | 001-38624 | 24800012 | 34 | 158924 | 1 | 1 |
| 2024-03-28 | 424B5 | 424B5 | 0001193125-24-080254 | 333-271074 | 24797091 | 33 | 318735 | |||
| 2024-03-27 | 8-K | 8-K | 8.01 | 0001193125-24-078295 | 001-38624 | 24785941 | 34 | 142878 | 1 | 1 |
| 2024-03-22 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-006960 | 15596 | ||||||
| 2024-03-22 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-006959 | 15356 | ||||||
| 2024-03-22 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-006958 | 13540 | ||||||
| 2024-03-22 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-006957 | 22128 | ||||||
| 2024-03-14 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-006424 | 13122 | ||||||
| 2024-03-04 | 8-K | 8-K | 5.02 | 0001193125-24-057888 | 001-38624 | 24715202 | 34 | 141160 | 1 | 1 |
| 2024-02-21 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-040885 | 001-38624 | 24656714 | 34 | 171066 | 1 | 1 |
| 2024-02-15 | 8-K | 8-K | 3.03,5.03,8.01,9.01 | 0001193125-24-037078 | 001-38624 | 24642187 | 34 | 201463 | 1 | 1 |
| 2024-02-13 | 8-K | 8-K | 5.07 | 0001193125-24-033801 | 001-38624 | 24626570 | 34 | 147752 | 1 | 1 |
| 2024-02-13 | SC 13D/A | SC 13D/A | 0001193125-24-033733 | 005-90610 | 24626128 | 34 | 134193 | |||
| 2024-02-12 | SC 13D/A | SC 13D/A | 0001193125-24-032098 | 005-90610 | 24620289 | 34 | 90093 | |||
| 2024-02-09 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-002770 | 24430 | ||||||
| 2024-02-09 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-002769 | 12547 | ||||||
| 2024-02-09 | SC 13G | VACCINEX, INC. | 0000902664-24-001362 | 005-90610 | 24614872 | 34 | 77268 | |||
| 2024-02-08 | 8-K/A | 8-K/A | 9.01 | 0001193125-24-027618 | 001-38624 | 24606953 | 34 | 273674 | 1 | 1 |
| 2024-02-07 | SC 13G/A | formsc13ga.htm | 0001493152-24-005339 | 005-90610 | 24606308 | 34 | 110772 | |||
| 2024-02-07 | 8-K | 8-K | 1.01,3.02,9.01 | 0001193125-24-026615 | 001-38624 | 24604129 | 34 | 732871 | 1 | 1 |
| 2024-01-19 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-01-19 09:00:00 | 9999999995-24-000161 | 333-276465 | 24546968 | 33 | 1787 | ||
| 2024-01-19 | 424B3 | 424B3 | 0001193125-24-011297 | 333-276465 | 24546139 | 33 | 198055 | |||
| 2024-01-17 | CORRESP | filename1.htm | 0001193125-24-008940 | 7226 | ||||||
| 2024-01-16 | UPLOAD | filename1.pdf | 0000000000-24-000489 | 333-276465 | 40303 | |||||
| 2024-01-10 | S-3 | S-3 | 0001193125-24-006026 | 333-276465 | 24527276 | 33 | 297528 | |||
| 2024-01-08 | DEF 14A | DEF 14A | 0001193125-24-004424 | 001-38624 | 24520328 | 34 | 297602 | |||
| 2023-12-28 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-023239 | 17480 | ||||||
| 2023-12-28 | PRE 14A | PRE 14A | 0001193125-23-305168 | 001-38624 | 231522873 | 34 | 221699 | |||
| 2023-12-12 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-022436 | 17602 | ||||||
| 2023-11-13 | 10-Q | 10-Q | 0000950170-23-062454 | 001-38624 | 231395160 | 34 | 6392292 | 1 | 1 | |
| 2023-11-03 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-020103 | 22466 | ||||||
| 2023-10-26 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-263647 | 001-38624 | 231347727 | 34 | 168093 | 1 | 1 |
| 2023-10-25 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-019700 | 38026 | ||||||
| 2023-10-18 | SC 13D/A | SC 13D/A | 0001193125-23-258489 | 005-90610 | 231332416 | 34 | 233733 | |||
| 2023-10-13 | 8-K | 8-K | 3.01,8.01 | 0001193125-23-256153 | 001-38624 | 231325541 | 34 | 153167 | 1 | 1 |
| 2023-10-12 | SC 13D/A | SC 13D/A | 0001193125-23-255043 | 005-90610 | 231323048 | 34 | 93033 | |||
| 2023-10-11 | SC 13G | formsc13g.htm | 0001493152-23-036885 | 005-90610 | 231320032 | 34 | 108072 | |||
| 2023-10-05 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-019063 | 25868 | ||||||
| 2023-10-05 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-019061 | 11202 | ||||||
| 2023-10-05 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-019059 | 39388 | ||||||
| 2023-10-04 | 8-K | 8-K | 1.01,9.01 | 0001193125-23-250405 | 001-38624 | 231306701 | 34 | 688922 | 1 | 1 |
| 2023-10-02 | 424B4 | 424B4 | 0001193125-23-248527 | 333-274520 | 231298125 | 33 | 221833 | |||
| 2023-09-28 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2023-09-28 17:00:00 | 9999999995-23-002823 | 333-274520 | 231291640 | 33 | 1739 | ||
| 2023-09-28 | S-1MEF | S-1MEF | 0001193125-23-246045 | 333-274756 | 231291472 | 33 | 99481 | |||
| 2023-09-27 | 8-K | 8-K | 7.01 | 0001193125-23-243082 | 001-38624 | 231281854 | 34 | 146225 | 1 | 1 |
| 2023-09-26 | SC 13D/A | SC 13D/A | 0001193125-23-242480 | 005-90610 | 231280626 | 34 | 59861 | |||
| 2023-09-26 | CORRESP | filename1.htm | 0001193125-23-242068 | 6783 | ||||||
| 2023-09-26 | CORRESP | filename1.htm | 0001193125-23-242064 | 6941 | ||||||
| 2023-09-26 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-241942 | 001-38624 | 231277194 | 34 | 270800 | 1 | 1 |
| 2023-09-26 | S-1/A | S-1/A | 0001193125-23-241928 | 333-274520 | 231277188 | 33 | 738143 | |||
| 2023-09-25 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-018438 | 18205 | ||||||
| 2023-09-22 | 8-K | 8-K | 3.03,5.03,8.01,9.01 | 0001193125-23-240553 | 001-38624 | 231272177 | 34 | 192772 | 1 | 1 |
| 2023-09-22 | 8-K | 8-K | 1.01,3.02,9.01 | 0001193125-23-240513 | 001-38624 | 231271968 | 34 | 464088 | 1 | 1 |
| 2023-09-20 | UPLOAD | filename1.pdf | 0000000000-23-010347 | 40251 | ||||||
| 2023-09-14 | S-1 | S-1 | 0001193125-23-235408 | 333-274520 | 231255972 | 33 | 357735 | |||
| 2023-09-13 | 8-K | 8-K | 5.07 | 0001193125-23-233884 | 001-38624 | 231251579 | 34 | 150656 | 1 | 1 |
| 2023-08-22 | 8-K | 8-K | 1.01,3.02,9.01 | 0001193125-23-218037 | 001-38624 | 231193937 | 34 | 429950 | 1 | 1 |
| 2023-08-14 | DEF 14A | DEF 14A | 0001193125-23-212402 | 001-38624 | 231170921 | 34 | 289908 | |||
| 2023-08-14 | 10-Q | 10-Q | 0000950170-23-042073 | 001-38624 | 231166405 | 34 | 6216003 | 1 | 1 | |
| 2023-08-04 | PRE 14A | PRE 14A | 0001193125-23-203956 | 001-38624 | 231144690 | 34 | 214328 | |||
| 2023-07-11 | 424B3 | 424B3 | 0001193125-23-184962 | 333-272649 | 231081160 | 33 | 159361 | |||
| 2023-07-10 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-07-10 17:00:00 | 9999999995-23-002038 | 333-272649 | 231081129 | 33 | 1739 | ||
| 2023-07-07 | CORRESP | filename1.htm | 0001193125-23-183865 | 7075 | ||||||
| 2023-06-20 | UPLOAD | filename1.pdf | 0000000000-23-006574 | 40222 | ||||||
| 2023-06-14 | S-3 | S-3 | 0001193125-23-166936 | 333-272649 | 231014894 | 33 | 521135 | |||
| 2023-05-30 | 8-K | 8-K | 3.01 | 0001193125-23-156073 | 001-38624 | 23971625 | 34 | 145143 | 1 | 1 |
| 2023-05-25 | SC 13D/A | SC 13D/A | 0001193125-23-154275 | 005-90610 | 23961213 | 34 | 117616 | |||
| 2023-05-19 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-149499 | 001-38624 | 23941484 | 34 | 166008 | 1 | 1 |
| 2023-05-19 | 424B5 | 424B5 | 0001193125-23-149497 | 333-271074 | 23941466 | 33 | 259323 | |||
| 2023-05-16 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-011230 | 8822 | ||||||
| 2023-05-15 | 8-K | 8-K | 1.01,3.02,9.01 | 0001193125-23-145153 | 001-38624 | 23923879 | 34 | 344668 | 1 | 1 |
| 2023-05-15 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-011116 | 9375 | ||||||
| 2023-05-15 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-011115 | 35158 | ||||||
| 2023-05-15 | 10-Q | 10-Q | 0000950170-23-022252 | 001-38624 | 23923228 | 34 | 5554046 | 1 | 1 | |
| 2023-05-15 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-011112 | 10722 | ||||||
| 2023-05-15 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-011110 | 12044 | ||||||
| 2023-05-15 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-011108 | 17529 | ||||||
| 2023-05-12 | 8-K | 8-K | 5.07 | 0001193125-23-142882 | 001-38624 | 23913357 | 34 | 149856 | 1 | 1 |
| 2023-04-12 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-04-12 16:30:00 | 9999999995-23-000913 | 333-271074 | 23816931 | 33 | 1738 | ||
| 2023-04-10 | CORRESP | filename1.htm | 0001193125-23-096533 | 5905 | ||||||
| 2023-04-07 | UPLOAD | filename1.pdf | 0000000000-23-003505 | 40266 | ||||||
| 2023-04-06 | ARS | ARS | 0001193125-23-093166 | 001-38624 | 23804468 | 34 | 14088574 | |||
| 2023-04-06 | DEF 14A | DEF 14A | 0001193125-23-093157 | 001-38624 | 23804458 | 34 | 383710 | |||
| 2023-04-05 | SC 13D/A | SC 13D/A | 0001193125-23-092337 | 005-90610 | 23802978 | 34 | 132811 | |||
| 2023-04-03 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-008326 | 14908 | ||||||
| 2023-04-03 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-008325 | 14257 | ||||||
| 2023-04-03 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-008324 | 34130 | ||||||
| 2023-04-03 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-008323 | 8819 | ||||||
| 2023-04-03 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-008322 | 14210 | ||||||
| 2023-04-03 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-008321 | 12968 | ||||||
| 2023-04-03 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-008320 | 18994 | ||||||
| 2023-04-03 | S-3 | S-3 | 0001193125-23-089051 | 333-271074 | 23790938 | 33 | 1053795 | |||
| 2023-04-03 | 8-K | 8-K | 1.01,3.02,9.01 | 0001193125-23-089004 | 001-38624 | 23790815 | 34 | 345063 | 1 | 1 |
| 2023-03-31 | 10-K | 10-K | 0000950170-23-011354 | 001-38624 | 23787370 | 34 | 14911613 | 1 | 1 | |
| 2023-03-23 | 8-K | 8-K | 5.02 | 0001193125-23-077886 | 001-38624 | 23756411 | 34 | 145756 | 1 | 1 |
| 2023-03-09 | 8-K | FORM 8-K | 7.01,9.01 | 0001193125-23-065339 | 001-38624 | 23718240 | 34 | 172843 | 1 | 1 |
| 2023-02-01 | 424B3 | 424B3 | 0001193125-23-020775 | 333-269385 | 23574633 | 33 | 117892 | |||
| 2023-01-31 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-01-31 16:30:00 | 9999999995-23-000245 | 333-269385 | 23574596 | 33 | 1738 | ||
| 2023-01-27 | CORRESP | filename1.htm | 0001193125-23-017528 | 5928 | ||||||
| 2023-01-26 | UPLOAD | filename1.pdf | 0000000000-23-000897 | 40187 | ||||||
| 2023-01-24 | S-3 | S-3 | 0001193125-23-014055 | 333-269385 | 23547099 | 33 | 219863 | |||
| 2023-01-04 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-000300 | 32883 | ||||||
| 2022-12-07 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-023491 | 16972 | ||||||
| 2022-11-29 | SC 13D/A | SC 13D/A | 0001193125-22-294363 | 005-90610 | 221433190 | 34 | 131748 | |||
| 2022-11-28 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-022815 | 16958 | ||||||
| 2022-11-28 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-022816 | 8996 | ||||||
| 2022-11-28 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-022814 | 31215 | ||||||
| 2022-11-28 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-022813 | 17232 | ||||||
| 2022-11-28 | SC 13D/A | SC 13D/A | 0001193125-22-293427 | 005-90610 | 221425936 | 34 | 62367 | |||
| 2022-11-25 | 8-K | 8-K | 1.01,3.02,9.01 | 0001193125-22-292625 | 001-38624 | 221420303 | 34 | 468257 | 1 | 1 |
| 2022-11-14 | 10-Q | 10-Q | 0001564590-22-037499 | 001-38624 | 221380417 | 34 | 6172170 | 1 | 1 | |
| 2022-11-10 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-282054 | 001-38624 | 221375238 | 34 | 199918 | 1 | 1 |
| 2022-10-11 | 8-K | 8-K | 3.01 | 0001193125-22-260706 | 001-38624 | 221304669 | 34 | 145607 | 1 | 1 |
| 2022-10-03 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-020146 | 31658 | ||||||
| 2022-09-13 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-243745 | 001-38624 | 221241122 | 34 | 2752614 | 1 | 1 |
| 2022-08-15 | 10-Q | 10-Q | 0001564590-22-029397 | 001-38624 | 221162428 | 34 | 5788477 | 1 | 1 | |
| 2022-08-08 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-214504 | 001-38624 | 221143126 | 34 | 182699 | 1 | 1 |
| 2022-08-01 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-207791 | 001-38624 | 221122838 | 34 | 10629888 | 1 | 1 |
| 2022-07-01 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-015746 | 30445 | ||||||
| 2022-06-10 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-171530 | 001-38624 | 221007664 | 34 | 8885089 | 1 | 1 |
| 2022-05-17 | 424B5 | 424B5 | 0001193125-22-152570 | 333-236416 | 22932491 | 33 | 13965 | |||
| 2022-05-16 | 10-Q | 10-Q | 0001564590-22-020252 | 001-38624 | 22925595 | 34 | 5225837 | 1 | 1 | |
| 2022-05-13 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-012390 | 7967 | ||||||
| 2022-05-13 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-012388 | 17337 | ||||||
| 2022-05-13 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-012386 | 9314 | ||||||
| 2022-05-13 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-012385 | 10637 | ||||||
| 2022-05-13 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-012384 | 28888 | ||||||
| 2022-05-13 | 8-K | 8-K | 5.07 | 0001193125-22-150166 | 001-38624 | 22923314 | 34 | 151867 | 1 | 1 |
| 2022-04-29 | 424B3 | 424B3 | 0001193125-22-133787 | 333-264236 | 22875683 | 33 | 160226 | |||
| 2022-04-27 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-04-27 16:30:00 | 9999999995-22-001124 | 333-264236 | 22861921 | 33 | 1738 | ||
| 2022-04-25 | CORRESP | filename1.htm | 0001193125-22-117561 | 6484 | ||||||
| 2022-04-14 | UPLOAD | filename1.pdf | 0000000000-22-004059 | 40199 | ||||||
| 2022-04-11 | S-3 | S-3 | 0001193125-22-101736 | 333-264236 | 22820089 | 33 | 268850 | |||
| 2022-04-05 | DEF 14A | DEF 14A | 0001193125-22-095655 | 001-38624 | 22805301 | 34 | 641041 | |||
| 2022-04-04 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-009451 | 12961 | ||||||
| 2022-04-04 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-009450 | 13659 | ||||||
| 2022-04-04 | 8-K | 8-K | 5.02 | 0001193125-22-095136 | 001-38624 | 22802877 | 34 | 146319 | 1 | 1 |
| 2022-04-04 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-009448 | 16866 | ||||||
| 2022-04-04 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-009446 | 12567 | ||||||
| 2022-04-04 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-009444 | 11719 | ||||||
| 2022-04-04 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-009441 | 27858 | ||||||
| 2022-03-31 | 10-K | 10-K | 0001564590-22-012778 | 001-38624 | 22789359 | 34 | 15125171 | 1 | 1 | |
| 2022-03-08 | 8-K | 8-K | 5.02 | 0001193125-22-069387 | 001-38624 | 22722564 | 34 | 143197 | 1 | 1 |
| 2022-02-24 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-005567 | 17229 | ||||||
| 2022-02-14 | SC 13D/A | SC 13D/A | 0001193125-22-040223 | 005-90610 | 22626817 | 34 | 135734 | |||
| 2022-02-10 | SC 13D | SC 13D | 0001193125-22-034655 | 005-90610 | 22615313 | 34 | 70876 | |||
| 2022-01-31 | 8-K | 8-K | 1.01,3.02,8.01,9.01 | 0001193125-22-023545 | 001-38624 | 22575333 | 34 | 548760 | 1 | 1 |
| 2022-01-31 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-001868 | 26275 | ||||||
| 2022-01-31 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-001867 | 9869 | ||||||
| 2022-01-31 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-001866 | 15444 | ||||||
| 2022-01-26 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-017722 | 001-38624 | 22555728 | 34 | 179604 | 1 | 1 |
| 2022-01-03 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-000063 | 26648 | ||||||
| 2021-11-08 | 10-Q | 10-Q | 0001564590-21-055065 | 001-38624 | 211386562 | 34 | 6857607 | 1 | 1 | |
| 2021-10-04 | 4 | PRIMARY DOCUMENT | 0000891839-21-000316 | 25511 | ||||||
| 2021-08-16 | 10-Q | 10-Q | 0001564590-21-044453 | 001-38624 | 211174602 | 34 | 6596599 | 1 | 1 | |
| 2021-08-03 | 8-K | 8-K | 1.02 | 0001193125-21-234931 | 001-38624 | 211139766 | 34 | 145410 | 1 | 1 |
| 2021-07-02 | 4 | PRIMARY DOCUMENT | 0000891839-21-000247 | 24055 | ||||||
| 2021-06-28 | 4 | PRIMARY DOCUMENT | 0000891839-21-000234 | 30987 | ||||||
| 2021-06-24 | 4 | PRIMARY DOCUMENT | 0000891839-21-000232 | 15349 | ||||||
| 2021-05-21 | 3 | PRIMARY DOCUMENT | 0000891839-21-000168 | 12072 | ||||||
| 2021-05-17 | 8-K | 8-K | 2.02,5.02,9.01 | 0001193125-21-162841 | 001-38624 | 21927712 | 34 | 49054 | ||
| 2021-05-17 | 10-Q | 10-Q | 0001564590-21-028189 | 001-38624 | 21927650 | 34 | 4929235 | 1 | ||
| 2021-05-12 | 4 | PRIMARY DOCUMENT | 0000891839-21-000140 | 11177 | ||||||
| 2021-05-12 | 4 | PRIMARY DOCUMENT | 0000891839-21-000139 | 8049 | ||||||
| 2021-05-12 | 4 | PRIMARY DOCUMENT | 0000891839-21-000138 | 9372 | ||||||
| 2021-05-12 | 4 | PRIMARY DOCUMENT | 0000891839-21-000137 | 6702 | ||||||
| 2021-05-12 | 4 | PRIMARY DOCUMENT | 0000891839-21-000136 | 15464 | ||||||
| 2021-05-12 | 4 | PRIMARY DOCUMENT | 0000891839-21-000135 | 26026 | ||||||
| 2021-05-12 | 8-K | 8-K | 5.07 | 0001193125-21-159064 | 001-38624 | 21915263 | 34 | 23616 | ||
| 2021-04-06 | DEF 14A | DEF 14A | 0001193125-21-107654 | 001-38624 | 21809572 | 34 | 354566 | |||
| 2021-04-02 | 4 | PRIMARY DOCUMENT | 0000891839-21-000101 | 10372 | ||||||
| 2021-04-02 | 4 | PRIMARY DOCUMENT | 0000891839-21-000100 | 15374 | ||||||
| 2021-04-02 | 4 | PRIMARY DOCUMENT | 0000891839-21-000099 | 12141 | ||||||
| 2021-04-02 | 4 | PRIMARY DOCUMENT | 0000891839-21-000098 | 11449 | ||||||
| 2021-04-01 | 4 | PRIMARY DOCUMENT | 0000891839-21-000089 | 25000 | ||||||
| 2021-03-31 | 10-K | 10-K | 0001564590-21-016874 | 001-38624 | 21789877 | 34 | 10892279 | 1 | ||
| 2021-03-25 | 8-K | 8-K | 5.02 | 0001193125-21-094459 | 001-38624 | 21772558 | 34 | 19043 | ||
| 2021-03-16 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-082168 | 001-38624 | 21743669 | 34 | 51157 | ||
| 2021-02-19 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-048682 | 001-38624 | 21653729 | 34 | 31525 | ||
| 2021-02-16 | SC 13G/A | SCHEDULE 13G (AMENDMENT #1) | 0000899140-21-000310 | 005-90610 | 21637205 | 34 | 41173 | |||
| 2021-02-12 | SC 13G/A | vaccinex13ga_02102021.htm | 0001123292-21-000243 | 005-90610 | 21628354 | 34 | 246508 | |||
| 2021-01-04 | 4 | PRIMARY DOCUMENT | 0000891839-21-000004 | 23787 | ||||||
| 2020-12-09 | 8-K/A | 8-K/A | 5.02 | 0001193125-20-313834 | 001-38624 | 201378198 | 34 | 19585 | ||
| 2020-11-20 | 10-Q/A | 10-Q/A | 0001193125-20-298336 | 001-38624 | 201329913 | 34 | 39850 | |||
| 2020-11-13 | 10-Q | 10-Q | 0001564590-20-053729 | 001-38624 | 201309170 | 34 | 5885279 | 1 | ||
| 2020-10-26 | 8-K | 8-K | 5.02 | 0001193125-20-276927 | 001-38624 | 201260886 | 34 | 17544 | ||
| 2020-10-19 | SC 13G | SCHEDULE 13G | 0001104659-20-115880 | 005-90610 | 201245478 | 34 | 32616 | |||
| 2020-10-01 | 4 | PRIMARY DOCUMENT | 0000891839-20-000296 | 22571 | ||||||
| 2020-09-22 | 8-K | FORM 8-K | 8.01,9.01 | 0001193125-20-250645 | 001-38624 | 201187873 | 34 | 34291 | ||
| 2020-09-16 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-20-016794 | 021-375681 | 201178999 | 33 | 12885 | ||
| 2020-09-09 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-242257 | 001-38624 | 201167038 | 34 | 33619 | ||
| 2020-09-09 | 424B5 | 424B5 | 0001193125-20-242246 | 333-236416 | 201166987 | 33 | 443189 | |||
| 2020-09-03 | 4 | PRIMARY DOCUMENT | 0000891839-20-000256 | 9730 | ||||||
| 2020-09-03 | 4/A | PRIMARY DOCUMENT | 0000891839-20-000255 | 6860 | ||||||
| 2020-09-01 | 4 | PRIMARY DOCUMENT | 0000891839-20-000254 | 5304 | ||||||
| 2020-09-01 | 3 | PRIMARY DOCUMENT | 0000891839-20-000253 | 5847 | ||||||
| 2020-08-27 | 8-K | FORM 8-K | 5.02,9.01 | 0001193125-20-232105 | 001-38624 | 201139078 | 34 | 30623 | ||
| 2020-08-25 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2020-08-25 16:30:00 | 9999999995-20-002255 | 333-246326 | 201134069 | 33 | 1739 | ||
| 2020-08-25 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2020-08-25 16:30:00 | 9999999995-20-002254 | 333-246322 | 201134068 | 33 | 1739 | ||
| 2020-08-21 | CORRESP | filename1.htm | 0001193125-20-227003 | 5617 | ||||||
| 2020-08-21 | CORRESP | filename1.htm | 0001193125-20-227000 | 5616 | ||||||
| 2020-08-21 | S-3/A | FORM S-3/A | 0001193125-20-226994 | 333-246326 | 201123512 | 33 | 73940 | |||
| 2020-08-20 | UPLOAD | filename1.pdf | 0000000000-20-007747 | 40154 | ||||||
| 2020-08-20 | UPLOAD | filename1.pdf | 0000000000-20-007746 | 40154 | ||||||
| 2020-08-14 | 8-K | FORM 8-K | 8.01,9.01 | 0001193125-20-220425 | 001-38624 | 201105659 | 34 | 33745 | ||
| 2020-08-14 | 424B5 | 424B5 | 0001193125-20-220408 | 333-236416 | 201105554 | 33 | 446884 | |||
| 2020-08-14 | S-3 | FORM S-3 | 0001193125-20-220395 | 333-246326 | 201105442 | 33 | 236590 | |||
| 2020-08-14 | S-3 | S-3 | 0001193125-20-220385 | 333-246322 | 201105355 | 33 | 231338 | |||
| 2020-08-14 | 10-Q | 10-Q | 0001564590-20-040174 | 001-38624 | 201101360 | 34 | 5926970 | 1 | ||
| 2020-08-11 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-20-014734 | 021-372997 | 201092577 | 33 | 12881 | ||
| 2020-07-31 | 8-K | 8-K | 1.01,2.03,3.02,9.01 | 0001193125-20-205401 | 001-38624 | 201063950 | 34 | 573256 | ||
| 2020-07-28 | 4/A | PRIMARY DOCUMENT | 0000891839-20-000214 | 13734 | ||||||
| 2020-07-27 | 4 | PRIMARY DOCUMENT | 0000891839-20-000213 | 11427 | ||||||
| 2020-07-16 | SC 13G | SCHEDULE 13G | 0000899140-20-000338 | 005-90610 | 201032173 | 34 | 48945 | |||
| 2020-07-16 | SC 13D/A | SC 13D/A | 0001019056-20-000418 | 005-90610 | 201031176 | 34 | 228116 | |||
| 2020-07-15 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-20-013306 | 021-371107 | 201029939 | 33 | 13624 | ||
| 2020-07-10 | 4 | PRIMARY DOCUMENT | 0000891839-20-000208 | 12651 | ||||||
| 2020-07-10 | 8-K | FORM 8-K | 1.01,3.02,9.01 | 0001193125-20-190745 | 001-38624 | 201021821 | 34 | 295467 | ||
| 2020-07-02 | 4 | PRIMARY DOCUMENT | 0000891839-20-000205 | 21358 | ||||||
| 2020-05-18 | 4 | PRIMARY DOCUMENT | 0000891839-20-000122 | 20829 | ||||||
| 2020-05-18 | 4 | PRIMARY DOCUMENT | 0000891839-20-000121 | 10255 | ||||||
| 2020-05-18 | 4 | PRIMARY DOCUMENT | 0000891839-20-000120 | 6769 | ||||||
| 2020-05-18 | 4 | PRIMARY DOCUMENT | 0000891839-20-000119 | 14838 | ||||||
| 2020-05-18 | 4 | PRIMARY DOCUMENT | 0000891839-20-000118 | 8201 | ||||||
| 2020-05-18 | 4 | PRIMARY DOCUMENT | 0000891839-20-000117 | 5313 | ||||||
| 2020-05-18 | 3 | PRIMARY DOCUMENT | 0000891839-20-000116 | 5798 | ||||||
| 2020-05-18 | 8-K | 8-K | 5.02,5.07 | 0001193125-20-144556 | 001-38624 | 20888095 | 34 | 24021 | ||
| 2020-05-14 | 10-Q | 10-Q | 0001564590-20-025279 | 001-38624 | 20875403 | 34 | 4403153 | 1 | ||
| 2020-04-08 | DEF 14A | DEF 14A | 0001193125-20-101408 | 001-38624 | 20782273 | 34 | 645358 | |||
| 2020-04-01 | 4 | PRIMARY DOCUMENT | 0000891839-20-000086 | 20011 | ||||||
| 2020-03-30 | 4 | PRIMARY DOCUMENT | 0000891839-20-000084 | 14381 | ||||||
| 2020-03-27 | 8-K | vaccinexform8k.htm | 1.01,8.01,9.01 | 0001123292-20-000631 | 001-38624 | 20752974 | 34 | 768373 | ||
| 2020-03-27 | 424B5 | 424B5 | 0001193125-20-088935 | 333-236416 | 20752830 | 33 | 674200 | |||
| 2020-03-27 | 424B5 | 424B5 | 0001193125-20-088913 | 333-236416 | 20752717 | 33 | 698066 | |||
| 2020-03-26 | 4 | PRIMARY DOCUMENT | 0000891839-20-000083 | 14381 | ||||||
| 2020-03-23 | 4 | PRIMARY DOCUMENT | 0000891839-20-000079 | 14381 | ||||||
| 2020-03-17 | 4 | PRIMARY DOCUMENT | 0000891839-20-000078 | 15955 | ||||||
| 2020-03-12 | UPLOAD | filename1.pdf | 0000000000-20-002211 | 45961 | ||||||
| 2020-03-11 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2020-03-11 17:00:00 | 9999999995-20-000552 | 333-236417 | 20707065 | 33 | 1738 | ||
| 2020-03-11 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2020-03-11 17:00:00 | 9999999995-20-000551 | 333-236416 | 20707064 | 33 | 1738 | ||
| 2020-03-11 | 4 | PRIMARY DOCUMENT | 0000891839-20-000075 | 14380 | ||||||
| 2020-03-09 | CORRESP | filename1.htm | 0001193125-20-067342 | 5573 | ||||||
| 2020-03-09 | CORRESP | filename1.htm | 0001193125-20-067341 | 5572 | ||||||
| 2020-03-09 | 10-K | 10-K | 0001564590-20-009251 | 001-38624 | 20696542 | 34 | 8308324 | 1 | ||
| 2020-02-26 | 8-K | 8-K | 5.02 | 0001193125-20-050123 | 001-38624 | 20656179 | 34 | 19439 | ||
| 2020-02-26 | 4 | PRIMARY DOCUMENT | 0000891839-20-000054 | 14481 | ||||||
| 2020-02-26 | 4 | PRIMARY DOCUMENT | 0000891839-20-000053 | 10466 | ||||||
| 2020-02-26 | 4 | PRIMARY DOCUMENT | 0000891839-20-000052 | 10791 | ||||||
| 2020-02-26 | 4 | PRIMARY DOCUMENT | 0000891839-20-000051 | 11785 | ||||||
| 2020-02-26 | 4 | PRIMARY DOCUMENT | 0000891839-20-000050 | 9263 | ||||||
| 2020-02-19 | UPLOAD | filename1.pdf | 0000000000-20-001533 | 39898 | ||||||
| 2020-02-13 | S-3 | S-3 | 0001193125-20-035658 | 333-236417 | 20611303 | 33 | 488941 | |||
| 2020-02-13 | S-3 | FORM S-3 | 0001193125-20-035616 | 333-236416 | 20611046 | 33 | 425950 | |||
| 2020-02-10 | 3/A | PRIMARY DOCUMENT | 0000891839-20-000038 | 3919 | ||||||
| 2020-02-03 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-20-001927 | 021-359631 | 20568722 | 33 | 12917 | ||
| 2020-01-27 | 4 | PRIMARY DOCUMENT | 0000891839-20-000034 | 12590 | ||||||
| 2020-01-27 | 4 | PRIMARY DOCUMENT | 0000891839-20-000033 | 18022 | ||||||
| 2020-01-27 | 4 | PRIMARY DOCUMENT | 0000891839-20-000032 | 12860 | ||||||
| 2020-01-27 | SC 13D/A | SC 13D/A | 0001019056-20-000029 | 005-90610 | 20548267 | 34 | 234238 | |||
| 2020-01-23 | 8-K | 8-K | 1.01,3.02,9.01 | 0001193125-20-013119 | 001-38624 | 20542500 | 34 | 310857 | ||
| 2020-01-15 | 4 | PRIMARY DOCUMENT | 0000891839-20-000030 | 12478 | ||||||
| 2020-01-15 | 4 | PRIMARY DOCUMENT | 0000891839-20-000029 | 15089 | ||||||
| 2020-01-06 | 4 | PRIMARY DOCUMENT | 0000891839-20-000018 | 13805 | ||||||
| 2020-01-06 | 4 | PRIMARY DOCUMENT | 0000891839-20-000017 | 16416 | ||||||
| 2020-01-06 | 4/A | PRIMARY DOCUMENT | 0000891839-20-000016 | 5794 | ||||||
| 2020-01-06 | 4/A | PRIMARY DOCUMENT | 0000891839-20-000015 | 5778 | ||||||
| 2019-11-12 | 10-Q | 10-Q | 0001564590-19-042537 | 001-38624 | 191206064 | 34 | 5969472 | 1 | ||
| 2019-10-08 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2019-10-08 17:00:00 | 9999999995-19-002272 | 333-233607 | 191143653 | 33 | 1739 | ||
| 2019-10-04 | CORRESP | filename1.htm | 0001193125-19-262780 | 6420 | ||||||
| 2019-10-04 | 4/A | FORM 4/A SUBMISSION | 0001209191-19-052508 | 001-38624 | 191137925 | 34 | 12482 | |||
| 2019-10-04 | 4/A | FORM 4/A SUBMISSION | 0001209191-19-052507 | 001-38624 | 191137887 | 34 | 15103 | |||
| 2019-10-04 | 4 | FORM 4 SUBMISSION | 0001209191-19-052506 | 11984 | ||||||
| 2019-10-04 | 4 | FORM 4 SUBMISSION | 0001209191-19-052505 | 14590 | ||||||
| 2019-10-02 | 4 | FORM 4 SUBMISSION | 0001209191-19-051418 | 001-38624 | 191130866 | 34 | 14932 | |||
| 2019-10-02 | 4 | FORM 4 SUBMISSION | 0001209191-19-051415 | 001-38624 | 191130783 | 34 | 12312 | |||
| 2019-09-27 | S-3/A | S-3/A | 0001193125-19-257629 | 333-233607 | 191123849 | 33 | 446426 | |||
| 2019-09-27 | CORRESP | filename1.htm | 0001193125-19-257641 | 14607 | ||||||
| 2019-09-18 | UPLOAD | filename1.pdf | 0000000000-19-013686 | 43545 | ||||||
| 2019-09-03 | S-3 | FORM S-3 | 0001193125-19-236677 | 333-233607 | 191072693 | 33 | 465225 | |||
| 2019-08-15 | SC 13G/A | msdpartnersvaccinex13g.htm | 0001123292-19-001061 | 005-90610 | 191031110 | 34 | 247938 | |||
| 2019-08-14 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-19-016996 | 021-346576 | 191026500 | 33 | 12920 | ||
| 2019-08-14 | 10-Q | 10-Q | 0001564590-19-031978 | 001-38624 | 191023014 | 34 | 5569352 | 1 | ||
| 2019-08-09 | SC 13G | msdpartnersvaccinex13g.htm | 0001123292-19-001042 | 005-90610 | 191013722 | 34 | 281551 | |||
| 2019-07-31 | SC 13D/A | SC 13D/A | 0001019056-19-000441 | 005-90610 | 19989235 | 34 | 227264 | |||
| 2019-07-31 | 4 | PRIMARY DOCUMENT | 0000891839-19-000143 | 14321 | ||||||
| 2019-07-31 | 4 | PRIMARY DOCUMENT | 0000891839-19-000142 | 12776 | ||||||
| 2019-07-31 | 8-K | FORM 8-K | 1.01,3.02,9.01 | 0001193125-19-207783 | 001-38624 | 19987361 | 34 | 302259 | ||
| 2019-07-29 | 4 | PRIMARY DOCUMENT | 0000891839-19-000134 | 14376 |
One latest value per concept from companyfacts (221 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 2.68M | 2025-04-11 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 5.58M | 2024-06-30 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 3.96M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 838,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 44,000 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001564590-21-016874 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 1.10M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 111,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 7.18M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 222.40M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 354.42M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 341,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 985,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-31 | 0000950170-23-011354 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 1.99M | 2024-07-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0000950170-24-127139 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 341,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 308,000 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | Assets | Assets | USD | 2.60M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 2.53M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 0 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 14.11M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 | |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 16.12M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-13 | 0001564590-18-029125 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 16.12M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-13 | 0001564590-18-029125 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 14.11M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 7,000 | 2021-01-01 | 2021-09-30 | 2022 | Q3 | 10-Q | 2022-11-14 | 0001564590-22-037499 |
| us-gaap | Cash | Cash | USD | 1.30M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-14 | 0001564590-18-021566 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 1.11M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -339,000 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-14 | 0001564590-19-031978 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 1.11M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -428,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 3.01M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 100.00M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 2.68M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 2.68M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 1,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -18.63M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | ConvertibleDebt | Convertible Debt | USD | 0 | 2021-08-03 | 2022 | FY | 10-K | 2023-03-31 | 0000950170-23-011354 | |
| us-gaap | ConvertibleLongTermNotesPayable | Convertible Notes Payable, Noncurrent | USD | 1.28M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-14 | 0001564590-18-021566 | |
| us-gaap | ConvertibleNotesPayableCurrent | Convertible Notes Payable, Current | USD | 1.28M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-14 | 0001564590-18-021566 | |
| us-gaap | CostOfRevenue | Cost of Revenue | USD | 2,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012778 |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 19.34M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | DebtInstrumentBasisSpreadOnVariableRate1 | Debt Instrument, Basis Spread on Variable Rate | pure | 0.02 | 2017-10-01 | 2017-10-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 6.00M | 2017-10-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 | |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | USD | 10.00M | 2017-01-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 | |
| us-gaap | DebtInstrumentPeriodicPaymentPrincipal | Debt Instrument, Periodic Payment, Principal | USD | 6.00M | 2017-01-01 | 2017-01-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 |
| us-gaap | DebtInstrumentUnamortizedDiscount | Debt Instrument, Unamortized Discount | USD | 223,000 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-14 | 0001564590-18-021566 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012778 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 42,000 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-13 | 0001564590-18-029125 | |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 78,000 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 | |
| us-gaap | DeferredTaxAssetsDerivativeInstruments | Deferred Tax Assets, Derivative Instruments | USD | 96,000 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 115.49M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 24.63M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 696,000 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 82.34M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 633,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves | USD | 76,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 115.49M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts | Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs | USD | 696,000 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 | |
| us-gaap | DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | pure | 1 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | Depreciation | Depreciation | USD | 94,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 249,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 |
| us-gaap | DerivativeAssets | Derivative Asset | USD | 14 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0000950170-24-127139 | |
| us-gaap | DerivativeAssetsCurrent | Derivative Asset, Current | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | DerivativeGainLossOnDerivativeNet | Derivative, Gain (Loss) on Derivative, Net | USD | 369,000 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 |
| us-gaap | DerivativeLiabilities | Derivative Liability | USD | 369,000 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 | |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | DerivativeLiabilitiesNoncurrent | Derivative Liability, Noncurrent | USD | 369,000 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 | |
| us-gaap | DividendsPayableCurrentAndNoncurrent | Dividends Payable | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 | |
| us-gaap | DividendsPreferredStock | Dividends, Preferred Stock | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -8.88 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.12 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-16 | 0001564590-22-020252 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -8.88 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.312 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | -1.103 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0.004 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.053 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.045 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability | Embedded Derivative, Fair Value of Embedded Derivative Liability | USD | 0 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012778 | |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 223,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 242,067 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | -1.29M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues | USD | 3.42M | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 |
| us-gaap | FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) | USD | -369,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | -2.38M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 6.79M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -18.63M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | IncomeTaxExaminationInterestAccrued | Income Tax Examination, Interest Accrued | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | IncomeTaxExaminationPenaltiesAccrued | Income Tax Examination, Penalties Accrued | USD | 0 | 2023-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 1.91M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -123,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -138,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -298,000 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -63,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | IncreaseDecreaseInDerivativeLiabilities | Increase (Decrease) in Derivative Liabilities | USD | -65,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012778 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -267,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | InterestExpense | Interest Expense | USD | 2,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | InterestExpenseDebt | Interest Expense, Debt | USD | 458,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-31 | 0000950170-23-011354 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 275,000 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 192,000 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 | |
| us-gaap | InterestPayableCurrentAndNoncurrent | Interest Payable | USD | 390,000 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-14 | 0001564590-18-021566 | |
| us-gaap | LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate | pure | 0.07 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0000950170-24-127139 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 4,718 | 2023-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | Liabilities | Liabilities | USD | 5.08M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 2.60M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 5.08M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 25,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 1.89M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-14 | 0001564590-18-021566 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 | |
| us-gaap | MinorityInterest | Stockholders' Equity Attributable to Noncontrolling Interest | USD | 23.96M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012778 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 15.78M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -22,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -16.19M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -18.63M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | NetIncomeLossAttributableToNoncontrollingInterest | Net Income (Loss) Attributable to Noncontrolling Interest | USD | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-14 | 0001564590-22-037499 |
| us-gaap | NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 | Noncash or Part Noncash Acquisition, Fixed Assets Acquired | USD | 19,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-31 | 0000950170-23-011354 |
| us-gaap | NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest | Noncontrolling Interest, Increase from Sale of Parent Equity Interest | USD | 12.00M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 |
| us-gaap | NotesPayableRelatedPartiesClassifiedCurrent | Notes Payable, Related Parties, Current | USD | 1.28M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-14 | 0001564590-18-021566 | |
| us-gaap | NotesPayableRelatedPartiesNoncurrent | Notes Payable, Related Parties, Noncurrent | USD | 2.81M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-04-25 | 0000950170-24-048163 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -18.73M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 181,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 145,764 | 2023-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 146,000 | 2022-12-31 | 2023 | FY | 10-K/A | 2024-04-25 | 0000950170-24-048163 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 181,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 150,480 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 174,132 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001564590-21-016874 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 0 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-14 | 0001564590-20-040174 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 0 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-14 | 0001564590-20-040174 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 150.48M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-14 | 0001564590-22-037499 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 331,060 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-31 | 0000950170-23-011354 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 44.61M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-14 | 0001564590-22-037499 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 45,144 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-15 | 0000950170-23-022252 |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 77,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 41,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | PaymentsOfDebtExtinguishmentCosts | Payment for Debt Extinguishment or Debt Prepayment Cost | USD | 0 | 2021-08-03 | 2022 | FY | 10-K | 2023-03-31 | 0000950170-23-011354 | |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 50,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012778 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 985,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-31 | 0000950170-23-011354 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 20.76M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 22,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | PreferredStockDividendsIncomeStatementImpact | Preferred Stock Dividends, Income Statement Impact | USD | 3.21M | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 |
| us-gaap | PreferredStockLiquidationPreferenceValue | Preferred Stock, Liquidation Preference, Value | USD | 1.75B | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 10 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 10 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 1.67M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 586,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | ProceedsFromContributedCapital | Proceeds from Contributed Capital | USD | 11.50M | 2020-03-27 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 37.13M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 1.27M | 2023-01-01 | 2023-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0000950170-24-127139 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 1.13M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012778 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants | Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants | USD | 1.70M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 7.30M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 9.98M | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 14.15M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-31 | 0001564590-21-016874 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 19,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012778 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 5.92M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -18.63M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 7.25M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 65,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 76,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | RepaymentsOfRelatedPartyDebt | Repayments of Related Party Debt | USD | 5.50M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009251 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 12.54M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -358.56M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 601,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 300,000 | 2021-01-01 | 2022 | FY | 10-K | 2023-03-31 | 0000950170-23-011354 | |
| us-gaap | SaleOfStockConsiderationReceivedOnTransaction | Sale of Stock, Consideration Received on Transaction | USD | 37.60M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012778 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 341,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 0 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0000950170-24-127139 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 14,534 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 327.7 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 3,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012778 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 24 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 15,784 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 73,906 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 3.79 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 4,000 | 2022-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 72,421 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 79.21 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 3,000 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-14 | 0001564590-20-025279 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 453,057 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 5.11 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012778 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 3,129 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 76.93 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 5.75 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price | USD/shares | 9.49 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-13 | 0001564590-18-029125 | |
| us-gaap | SharesOutstanding | Shares, Outstanding | shares | 4.86M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0000950170-23-062454 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 7.41M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012778 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | -2.49M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.14 | 2024-02-19 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 3,783 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012778 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 111.72M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 2,000 | 2024-01-01 | 2024-03-31 | 2024 | Q3 | 10-Q | 2024-11-14 | 0000950170-24-127139 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 19,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012778 |
| us-gaap | TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests | Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests | USD | 111.72M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 | |
| us-gaap | TemporaryEquityDividendsAdjustment | Temporary Equity, Dividends, Adjustment | USD | -1.59M | 2018-01-01 | 2018-06-30 | 2019 | Q2 | 10-Q | 2019-08-14 | 0001564590-19-031978 |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0.001 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 | |
| us-gaap | TreasuryStockCommonShares | Treasury Stock, Common, Shares | shares | 5 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | TreasuryStockPreferredShares | Treasury Stock, Preferred, Shares | shares | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-13 | 0001564590-19-007458 | |
| us-gaap | TreasuryStockSharesAcquired | Treasury Stock, Shares, Acquired | shares | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | TreasuryStockValue | Treasury Stock, Value | USD | 11,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | UnrealizedGainLossOnDerivatives | Unrealized Gain (Loss) on Derivatives | USD | -95,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 6.00M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 2.10M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 38.76M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-16 | 0001564590-22-020252 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 2.10M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0000950170-25-054318 |